Treating acne with antibiotic-resistant bacterial colonization (Q34167188)

31 July 2017

1 reference

title

Treating acne with antibiotic-resistant bacterial colonization (English)

1 reference

31 July 2017

main subject

antibiotic resistance

1 reference

0 references

Thrasivoulos Tzellos

1

1 reference

31 July 2017

Vasiliki Zampeli

series ordinal

2

1 reference

31 July 2017

Evgenia Makrantonaki

series ordinal

3

1 reference

31 July 2017

Christos C Zouboulis

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

28 February 2011

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

1233-1247

1 reference

Acne and sebaceous gland function

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

What is the pathogenesis of acne?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

New developments in our understanding of acne pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

21 January 2018

Sebaceous gland lipids.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

The skin as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

The role of Propionibacterium acnes in acne pathogenesis: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Acne vulgaris: a review of antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Propionibacterium acnes resistance: a worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Structures and biological activities of peptidoglycans of Listeria monocytogenes and Propionibacterium acnes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Inflammatory events are involved in acne lesion initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Cutaneous induction of corticotropin releasing hormone by Propionibacterium acnes extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Propionibacterium acnes and sebaceous lipogenesis: a love-hate relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

The complete genome sequence of Propionibacterium acnes, a commensal of human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

The role of innate immunity in the pathogenesis of acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Propionibacterium acnes resistance to antibiotics in acne patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Antibiotic-resistant acne: lessons from Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Bacterial resistance in acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Antibiotic resistance in Propionibacterium acnes. Microbiological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Treatment of acne with topical antibiotics: lessons from clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Biofilms: survival mechanisms of clinically relevant microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Antibiotic resistance of bacteria in biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Microbiology's principle of biofilms as a major factor in the pathogenesis of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

21 January 2018

Pharmacotherapy of acne

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Topical clindamycin in the management of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

An evaluation of dapsone gel 5% in the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Azithromycin: indications for the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Antibiotic-resistant acne: lessons from good sense.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Optimizing use of oral antibiotics in acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

The effect of zinc and erythromycin on the growth of erythromycin-resistant and erythromycin-sensitive isolates of Propionibacterium acnes: an in-vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Toxic effects associated with consumption of zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

An ultrastructural study of the retention hyperkeratosis of experimentally induced comedones in rabbits: the effects of three comedolytics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Anti-acne agents attenuate FGFR2 signal transduction in acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Combination azelaic acid therapy for acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Update and future of systemic acne treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Effects of 13-Cis-Retinoic Acid, All-Trans-Retinoic Acid, and Acitretin on the Proliferation, Lipid Synthesis and Keratin Expression of Cultured Human Sebocytes In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

The truth behind this undeniable efficacy--recurrence rates and relapse risk factors of acne treatment with oral isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defense system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

In vitro activities of three synthetic peptides derived from epinecidin-1 and an anti-lipopolysaccharide factor against Propionibacterium acnes, Candida albicans, and Trichomonas vaginalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

The effect of 2% niacinamide on facial sebum production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous lipogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Zileuton, a new efficient and safe systemic anti-acne drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

Evidence-based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab".

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.553192

10.1517/14656566.2011.553192

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference